NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AccuPulse Medical Technology

AccuPulse Medical Technology

Private
SuzhouHealthcare & Life Scienceshttps://accupulse.com/

Last Round

VC Round

Mar 13, 2026

Total Funding Raised

$56.2M

Company Overview

AccuPulse Medical Technology is a medical device company that develops AI-powered diagnostic and therapeutic solutions for cardiovascular diseases, specifically focusing on pulsed field ablation systems for treating atrial fibrillation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

hemodynamic monitoringpulsed field ablationPFAcardiac mappingelectrophysiology equipmentnon-invasive monitoringmedical device3D navigation systemclinical AIAI-driven diagnosticsmedtechcardiovascular diagnosticselectrophysiology labEP labmedical consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AccuPulse Medical Technology Comparables

Compare AccuPulse Medical Technology with similar companies based on industry and business-model similarity.

AccuPulse Medical Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Masimo Corporation
66%
Shanghai Yuanshan Medical Technology Co., Ltd.
61%
Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd.
58%

AccuPulse Medical Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 13, 2026
Series A ExtensionJun 17, 2024
Series A ExtensionFeb 26, 2024
Series AMay 20, 2022
Pre SeedNov 1, 2021
Angel
Nov 1, 2020

AccuPulse Medical Technology Investors

Notable investors and investment history

AccuPulse Medical Technology investors
InvestorRounds
CCIC CapitalVC Round
Yuanjing CapitalVC Round
YuanBio Venture CapitalVC Round
Legend CapitalSeries A Extension
Leadipo CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 6, 2024

    Grew 24% QoQ, from 21 to 26 employees.

  • Nov 1, 2021

    $8M round led by siicshc

AccuPulse Medical Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AccuPulse Medical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AccuPulse Medical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Employee Range25
Year Founded2020
Last FundingMar 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.